Trace amine associate receptor 1 (TAAR1) as a new target for the treatment of cognitive dysfunction in Alzheimer disease

被引：0
|
作者：
Leo, D. [1 ]
Espinoza, S. [2 ]
Villers, A. [3 ]
Gainetdinov R, R. [4 ]
Ris, L. [3 ]
机构：
[1] Univ Mons, Dept Neurosci, Mons, Belgium
[2] Ist Italiano Tecnol, Neurosci & Brain Technol, Genoa, Italy
[3] Univ Mons, Neurosci, Mons, Belgium
[4] St Petersburg State Univ, Inst Translat Biomed, St Petersburg, Russia
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2019年 / 29卷
关键词：
D O I：
10.1016/j.euroneuro.2019.09.487
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.479
引用
收藏
页码：S336 / S337
页数：2
相关论文
共 50 条
  • [21] Trace amine-associated Receptor 1 (TAAR1) as a positive prognostic Marker for epithelial Ovarian Carcinoma
    Vattai, A.
    Vogelsang, T. L. R.
    Schmoeckel, E.
    Kuhn, C.
    Mayr, D.
    Mahner, S.
    Jeschke, U.
    Trillsch, F.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (07) : 738 - 738
  • [22] Trace amine-associated receptor 1 (TAAR1): Potential application in mood disorders: A systematic review
    Alnefeesi, Yazen
    Tamura, Jocelyn K.
    Lui, Leanna M. W.
    Jawad, Muhammad Youshay
    Ceban, Felicia
    Ling, Susan
    Nasri, Flora
    Rosenblat, Joshua D.
    McIntyre, Roger S.
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2021, 131 : 192 - 210
  • [23] Potential of Ligands for Trace Amine-Associated Receptor 1 (TAAR1) in the Management of Substance Use Disorders
    Wu, Ruyan
    Li, Jun-Xu
    CNS DRUGS, 2021, 35 (12) : 1239 - 1248
  • [24] Potential of Ligands for Trace Amine-Associated Receptor 1 (TAAR1) in the Management of Substance Use Disorders
    Ruyan Wu
    Jun-Xu Li
    CNS Drugs, 2021, 35 : 1239 - 1248
  • [25] Stimulus Specific Adaptation Is Affected in Trace Amine-Associated Receptor 1 (TAAR1) Knockout Mice
    V. M. Knyazeva
    E. S. Dmitrieva
    N. V. Polyakova
    Y. A. Simon
    L. N. Stankevich
    A. Y. Aleksandrov
    A. A. Aleksandrov
    Journal of Evolutionary Biochemistry and Physiology, 2022, 58 : 692 - 699
  • [26] Stimulus Specific Adaptation Is Affected in Trace Amine-Associated Receptor 1 (TAAR1) Knockout Mice
    Knyazeva, V. M.
    Dmitrieva, E. S.
    Polyakova, N., V
    Simon, Y. A.
    Stankevich, L. N.
    Aleksandrov, A. Y.
    Aleksandrov, A. A.
    JOURNAL OF EVOLUTIONARY BIOCHEMISTRY AND PHYSIOLOGY, 2022, 58 (03) : 692 - 699
  • [27] Modulation of dopaminergic activity in the mesolimbic system by trace amine-associated receptor 1 (TAAR1) modification
    Revel, F. G.
    Bradaia, A.
    Trube, G.
    Stalder, H.
    Ozmen, L.
    Wettstein, J. G.
    Bettler, B.
    Hoener, M. C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S273 - S273
  • [28] TAAR1 as an emerging target for the treatment of psychiatric disorders
    Liu, Jianfeng
    Wu, Ruyan
    Li, Jun-Xu
    PHARMACOLOGY & THERAPEUTICS, 2024, 253
  • [29] The Molecular Basis of Species-Specific Ligand Activation of Trace Amine-Associated Receptor 1 (TAAR1)
    Tan, Edwin S.
    Naylor, John C.
    Groban, Eli S.
    Bunzow, James R.
    Jacobson, Matthew P.
    Grandy, David K.
    Scanlan, Thomas S.
    ACS CHEMICAL BIOLOGY, 2009, 4 (03) : 209 - 220
  • [30] Synthesis, radiolabeling and biological evaluation of a novel trace amine-associated receptor 1 (TAAR1) PET radioligand
    Haider, Ahmed
    Sun, Jiyun
    Chen, Jiahui
    Rong, Jian
    Shao, Tuo
    Wang, Lu
    Xu, Hao
    Zhang, Ming-Rong
    Liang, Steven
    NUCLEAR MEDICINE AND BIOLOGY, 2021, 96-97 : S37 - S38
12345